Main Menu

Preclinical Molecular Imaging Team

Dr Gabriela Kramer-Marek’s team uses cutting-edge biomedical imaging techniques to gain information about the way particular genes drive cancer progression.

The team’s long-term goal is to develop specific biomarkers for detecting cancers and to evaluate these biomarkers in pre-clinical cancer models

Group leader

Dr Gabriela Kramer-Marek

Dr Gabriela Kramer-Marek

Dr Gabriela Kramer-Marek is investigating new ways of molecular imaging in order to predict an individual patient’s response to treatment. Before moving to the ICR, she developed a new approach for non-invasive assessment of HER2 expression in breast cancer.

ORCID 0000-0002-8053-3880

Group members

Dr Chiara Da Pieve

Senior Scientific Officer 020 3437 6376

Dawoud Dar

Scientific Officer +44 20 3437 6785

David Turton

Higher Scientific Officer 020 3437 4549